Booz Allen Hamilton Holding Corporation (BIT:1BAH)

Ligand Pharmaceuticals Revenue

Booz Allen Hamilton Holding had revenue of $2.92B USD in the quarter ending June 30, 2025, a decrease of -0.61%. This brings the company's revenue in the last twelve months to $11.96B, up 9.25% year-over-year. In the fiscal year ending March 31, 2025, Booz Allen Hamilton Holding had annual revenue of $11.98B with 12.36% growth.

• Revenue (ttm): $11.96B
• Revenue Growth: +9.25%
• P/S Ratio: 1.15
• Revenue / Employee: $334.13K
• Employees: 35,800
• Market Cap: 11.74B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	11.98B	1.32B	12.36%
Mar 31, 2024	10.66B	1.40B	15.15%
Mar 31, 2023	9.26B	895.30M	10.70%
Mar 31, 2022	8.36B	504.76M	6.42%
Mar 31, 2021	7.86B	395.10M	5.29%